# Ameris Bancorp: overview

ABCB · NYSE · CIK 351569 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/abcb.md) · [Financials](/companies/abcb/financials.md) · [Filings](/companies/abcb/filings.md) · [Insiders](/companies/abcb/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [1.44](/filings/0000351569-25-000037.md) | not reported | [1.27](/filings/0000351569-26-000086.md) | [1.60](/filings/0000351569-26-000143.md) | [1.54](/filings/0000351569-25-000037.md) | not reported | [1.63](/filings/0000351569-26-000086.md) | [0.77](/filings/0000351569-26-000143.md) |
| Free cash flow | $m | [99.8 d](/filings/0000351569-25-000037.md) | [126 d](/filings/0000351569-26-000050.md) | [114](/filings/0000351569-26-000086.md) | [53.7 d](/filings/0000351569-26-000143.md) | [101 d](/filings/0000351569-25-000037.md) | [101 d](/filings/0000351569-26-000050.md) | [249](/filings/0000351569-26-000086.md) | [70.8 d](/filings/0000351569-26-000143.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [5.40](/filings/0000351569-24-000006.md) | [4.99](/filings/0000351569-25-000006.md) | [3.89](/filings/0000351569-26-000050.md) | [5.19](/filings/0000351569-26-000050.md) | [6.00](/filings/0000351569-26-000050.md) |
| Free cash flow | $m | [(16.3)](/filings/0000351569-24-000006.md) | [1,049](/filings/0000351569-25-000006.md) | [551](/filings/0000351569-26-000050.md) | [141](/filings/0000351569-26-000050.md) | [370](/filings/0000351569-26-000050.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/abcb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $881.8m | 9,769,532 |  | Reduced −48,874 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $352.1m | 3,900,747 |  | Added +4,121 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $335.4m | 3,716,080 |  | Added +22,011 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $315.7m | 3,490,328 |  | Added +170,532 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $279.1m | 3,091,817 |  | Added +496,500 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $261.1m | 2,892,605 |  | Added +1,665 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $258.8m | 2,867,288 |  | Reduced −29,057 |
| [North Reef Capital Management LP](/funds/1867831.md) | 2026-06-30 | $246.6m | 2,732,243 |  | Reduced −691,000 |
| [Independent Advisor Alliance](/funds/1696899.md) | 2026-06-30 | $239.0m | 2,647,824 |  | Added +67 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $199.2m | 2,206,771 |  | Added +1,090,268 |

## Recent filings

[All 1,248 filings](/companies/abcb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 20:15 ET | [8-K](/filings/0000351569-26-000156.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000351569-26-000156 |
| 2026-08-07 | 19:07 ET | [10-Q](/filings/0000351569-26-000143.md) | Quarterly report, period 2026-06-30 | 0000351569-26-000143 |
| 2026-07-23 | 20:16 ET | [8-K](/filings/0000351569-26-000139.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000351569-26-000139 |
| 2026-06-18 | 21:20 ET | [8-K](/filings/0000351569-26-000127.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000351569-26-000127 |
| 2026-06-12 | 21:20 ET | [8-K](/filings/0000351569-26-000123.md) | 8.01 Other events | 0000351569-26-000123 |
| 2026-05-26 | 20:17 ET | [8-K](/filings/0000351569-26-000119.md) | 5.07 Shareholder vote results | 0000351569-26-000119 |
| 2026-05-08 | 14:32 ET | [10-Q](/filings/0000351569-26-000086.md) | Quarterly report, period 2026-03-31 | 0000351569-26-000086 |
| 2026-04-23 | 20:20 ET | [8-K](/filings/0000351569-26-000079.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000351569-26-000079 |
| 2026-04-07 | 13:31 ET | [DEF 14A](/filings/0001140361-26-013509.md) | Proxy statement, period 2026-05-21 | 0001140361-26-013509 |
| 2026-02-26 | 20:44 ET | [10-K](/filings/0000351569-26-000050.md) | Annual report, period 2025-12-31 | 0000351569-26-000050 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000351569-26-000050.md), filed Feb 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 351569
- Tickers: ABCB
- Exchange: NYSE
- SIC code: 6022 State Commercial Banks
- State of incorporation: GA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.